WANG HUIRU has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are YOUNG DAVID S F, DESENTUM OY and ORBAN BIOTECH LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Foods | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Sugars | |
#9 | Fodder | |
#10 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Wang Huiru | 19 |
#2 | Wanghuiru | 1 |
#3 | Erxin Wang | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017139975A1 | Antibodies against n-acetylglucosamine and n-acetyl-galactosamine | |
WO2016026143A1 | Saccharide-based biomarkers and therapeutics | |
CN105051062A | Biological therapeutics for infection-relating disorders or conditions | |
US2016022713A1 | Compositions and Products for Infectious or Inflammatory Diseases or Conditions | |
CN102178686A | Medicament and vaccine for polysaccharide-related disease and immunoassay product | |
US2011085981A1 | Glycan-based drugs, therapies and biomarkers | |
EP2102656A2 | A process for identification of molecular mimicry and the uses thereof |